HomeNews

News

FDA Approval of Modeyso ‘Vital Step Ahead’ For Sufferers with Glioma

The accelerated approval from the U.S. Meals and Drug Administration (FDA) of Modeyso (dordaviprone) for sufferers with diffuse midline glioma with an H3...

Breast Most cancers Survivor Shares Advantages of Energy Coaching on Chemo

Breast most cancers survivor and researcher LaShae Rolle research how individualized energy coaching throughout chemo boosts bodily, psychological and emotional well being.LaShae D....

Why New Sufferers With A number of Myeloma ‘Can Count on Lengthy, Wholesome Lives’

For almost 30 years, Dr. Jim Omel has had a entrance row seat to the altering panorama of a number of myeloma therapy.Omel,...

Vonjo Improves Platelets and Hemoglobin in Sufferers With Myelofibrosis

Greater than half of sufferers with myelofibrosis with low platelets handled with Vonjo had a platelet response, with median platelets rising 58% and...

Actual-World Information on Remedy Outcomes in HER2-Adverse Breast Most cancers

Actual-world knowledge present the good thing about Enhertu and Trodelvy throughout HR+, HER2-null, and HER– illness: © inventory.adobe.com.Enhertu (trastuzumab deruxtecan; T-DXd) labored higher for...

Hot Topics